Triple-negative breast cancer (TNBC) is a heterogeneous group of breast cancers characterized by the loss of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) gene expression (70). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.